Camille L. Bedrosian, EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 9,086 shares at $138.18 ($1.3M) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $1.3M RARE by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.18 | 4,543 | $628K | 50.0% |
| 2 | $138.18 | 4,543 | $628K | 50.0% |
| Total | $138.18 avg | 9,086 | $1.3M | 100% |
| Filing → |
| AMLX | SELL | 2025-12-03 | $94K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $351K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |